본 보고서에서는 세계의 흉요추 고정장치 시장에 대해 조사했으며, 시장 개요와 함께 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공합니다.
목차
흉요추 고정 장치 시장
주요 요약
개요 : 세계의 흉요추 고정 장치 시장
경쟁 분석
시장 세분화
대상 지역
소개
퇴행성 흉요추 고정
흉요추 변형 교정
외상 및 종양 흉요추 고정
수기 건수
전흉 요추 고정술
변성 흉요추 고정술
변형 교정 흉요추 고정술
외상 및 종양 흉요추 고정술
시장 개요
부문별
지역별
시장 분석 및 예측
변형성 흉요추 고정장치 시장
변형 교정 흉요추 고정 장치 시장
외상 및 종양 흉요추 고정장치 시장
촉진요인과 억제요인
경쟁 시장 점유율 분석
JHS
영문 목차
영문목차
The global thoracolumbar fixation market was valued at over $6.3 billion in 2024.
It is projected to grow at a CAGR of 6.9% to exceed $10 billion by 2031.
The full report suite includes segmentation by:
Degenerative Thoracolumbar Fixation
Deformity Correction Thoracolumbar Fixation
Trauma/Tumor Thoracolumbar Fixation
Market Data Included
Unit Sales
Average Selling Prices (ASPs)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data to 2024
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
Global Thoracolumbar Fixation Market Trends
The primary limiting factor for spinal fusion, including thoracolumbar fixation, is the advancement of motion preservation technologies.
Lumbar Artificial Discs (LADs) have not yet significantly displaced fixation systems due to limited reimbursement and suboptimal clinical outcomes.
However, future improvements in LADs could pose a threat to thoracolumbar fixation device market share.
Global Thoracolumbar Fixation Market Share Insights
1 Medtronic
Market leader in 2024, especially dominant in North America.
Strong presence in degenerative fixation, largely due to the CD Horizon(R) Legacy(TM) system, the world's first PEEK-based pedicle screw/rod system.
Additional products under the CD Horizon(R) brand, such as Solera Voyager, continue to drive growth.
The TSRH(R) spinal system with CROSSLINK(R) plates serves across degenerative, deformity, and trauma/tumor indications.
Other key systems include Colorado 2(TM) (scoliosis) and TSRH-3D(R) (lordosis or sway back deformity).
2 DePuy Synthes
Second-largest competitor globally in 2024, with strong performance in Asia-Pacific and Latin America.
Offers anterior plate systems (ANTEGRA(TM) and ANTEGRA-T(TM)) for degenerative and trauma/tumor cases.
Comprehensive deformity product line includes EXPEDIUM(R) and MATRIX(R) systems, suited for degenerative and deformity indications.
3 Stryker
Ranked third in the global market in 2024.
Strong presence in North America and Western Europe, with expanding influence in Asia-Pacific and Latin America.
Key products: XIA(R) 4.5 Spinal System, XIA(R) 3 MIS System, and AcuLIF(TM) Expandable Lumbar Interbody System.
In 2025, sold non-core spinal implant assets (including thoracolumbar fixation systems) to Viscogliosi Brothers (VB) as part of a strategic focus on enabling technologies.
Despite divestment, Stryker maintains market influence through leadership in surgical navigation, robotics, and integrated procedural solutions.
Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
